Myosin VI contributes to maintaining epithelial barrier function

Journal of Biomedical Science

Research

Xiu-Ying Wu¹  Yu-Wei Liao¹  Tao Hong¹  Xiao-Lei Wu¹  Xing-Mao Wu¹  Ling-Xin Meng¹  Jia Jia¹ 

[1] Department of Anesthesiology, Shengjing Hospital, China Medical University, 36 Sanhao St, 110004, Shenyang, China;

关键词: Endosome;    Lysosome;    Epithelium;    Barrier function;    Myosin;   

DOI  :  10.1186/1423-0127-20-68

 received in 2013-06-20, accepted in 2013-09-10,  发布年份 2013

来源: Springer

【 摘 要 】

BackgroundEpithelial barrier dysfunction is associated with the pathogenesis of a number of immune inflammations; the etiology is not fully understood. The fusion of endosome/lysosome is a critical process in the degradation of endocytic antigens in epithelial cells. Recent reports indicate that myosin VI (myo6) is involved in the activities of endosomes. The present study aims to investigate the role of myo6 in epithelial barrier dysfunction.ResultsThe endosome accumulation was observed in myo6-deficient Rmcs. More than 80% endosomes were fused with lysosomes in naïve Rmcs while less than 30% endosomes were fused with lysosomes in the myo6-deficient Rmcs. The myo6-deficient Rmc monolayers showed high permeability to a macromolecular antigen, ovalbumin, the latter still conserved the antigenicity, which induced strong T cell activation.ConclusionsWe conclude that myo6 plays a critical role in the fusion of endosome/lysosome in Rmc epithelial cells. Deficiency of myo6 compromises the epithelial barrier function.

【 授权许可】

Unknown   
© Liao et al.; licensee BioMed Central Ltd. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.